Testing pentoxifylline and vitamin E for jaw bone damage
Part of Bones, joints & muscles, Mouth & dental clinical trials.
This trial tests a combination of medicines (pentoxifylline and tocopherol, a form of vitamin E) to treat damage to the jaw bone caused by bone-strengthening drugs. If you have Stage 2 MRONJ and meet other criteria, this treatment may help heal the bone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have taken or are taking a type of bone medication (bisphosphonate or denosumab).
- Your jaw has an exposed area of bone with signs of infection (this is called Stage 2 MRONJ).
- You have not had radiation to your head or neck, or cancer that spread to your jaw.
- You are not taking blood thinners, certain other medicines, or have bleeding problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at your risk of developing a rare jaw bone problem from certain bone-strengthening medications before, during, and after a needed dental procedure. Your participation could help find early warning signs and improve prevention.
This trial tests whether using a special blood product (leukocyte- and platelet-rich fibrin, or L-PRF) during surgery for a jawbone condition called MRONJ helps improve healing. Patients who need surgery under general anesthesia for advanced MRONJ may be able to join.
This trial tests whether putting a special blood concentrate from your own platelets into the tooth socket after an extraction helps the bone heal better and prevent a serious jaw condition (MRONJ) in people at high risk due to certain medications like bisphosphonates or denosumab.
This study looks at what changes happen in the jawbone in people with osteonecrosis of the jaw (a damaged jawbone area), whether or not they take certain cancer/bone medicines. It may help doctors better understand the condition and how it behaves over time.
This trial tests a combination of hyperbaric oxygen therapy and a medication called PENTOCLO to treat osteoradionecrosis (bone damage) in the jaw after radiation treatment for cancer. It may help heal the exposed bone.
This study follows patients with medication-related osteonecrosis of the jaw (a bone condition often caused by certain cancer or osteoporosis medicines) using imaging scans to understand how the bone changes over time. The goal is to better predict outcomes and improve treatment.
Hear when a new Medication-related Osteonecrosis of the Jaw (MRONJ) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.